Introduction
Hematopoietic stem cells (HSC) reside in a special bone marrow (BM) niche, which regulates their localization, self-renewal and differentiation. Studies have identified several major cell types of the niche, including mesenchymal stem cells (MSC), osteolineage cells (OLC), adipocytes and vascular endothelial cells (EC). [1] [2] [3] [4] [5] Besides the key cellular components, some growth and survival factors are also indispensable components of the niche, including C-X-C motif chemokine 12 ligand (CXCL12), vascular cell adhesion molecule1 (VCAM1), 6, 7 stem cell factor (SCF) 4 and osteopontin. 8 A sophisticated network of interactions between these multiple BM cells, extracellular factors and adhesion molecules is essential to regulate different HSC properties during homeostasis and keep normal hematopoiesis in check.
Acute myeloid leukemia (AML) has been considered for decades to be a disorder intrinsic to hematopoietic cells; however, evidence is accumulating that the microenvironment exerts more than a mere bystander effect. Leukemic cells can remodel the niche into a permissive environment favoring leukemic stem cell (LSC) expansion over normal HSC maintenance. 9 Recently, emerging evidence even points to a role for the BM niche as a driver of disease maintenance/progression. Krause et al. showed that osteoblast-specific activation of the parathyroid hormone receptor enhances MLL-AF9 oncogene-induced AML in mouse transplantation models. 10 To date, there are still few studies concerning the role of the bone marrow niche in initiating and maintaining AML and relevant mechanisms remain elusive.
TWIST1 is a highly conserved transcription factor belonging to the basic helixloop-helix family and is implicated in diverse developmental systems. [11] [12] [13] Studies have revealed that TWIST1 is a key regulator of MSC self-renewal, enhances their life-span, inhibits MSC osteo/chondrogenic differentiation and promotes adipogenic differentiation. [14] [15] [16] Twist1 haploisufficiency leads to Saethre-Chotzen syndrome, which is characterized by alterations in osteogenic precursor cell proliferation, differentiation and survival. 17 Recent studies have demonstrated that TWIST1 promotes angiogenesis by inducing EC proliferation and migration, and deregulation of this mechanism mediates pathological angiogenesis. 18, 19 Arthur et al. showed Niche TWIST1 is critical for maintaining normal hematopoiesis and impeding leukemia progression
However, the effects of TWIST1 on multiple niche elements and its modulation of normal HSC maintenance and leukemia progression in vivo have not been functionally characterized so far.
To explore this issue, we generated a murine model of a Twist1-deficient microenvironment. We showed that the major niche cellular components and factors changed remarkably upon Twist1 deletion, causing severe dysfunction of normal HSC. Nevertheless, these alterations of the BM microenvironment promoted MLL-AF9 oncogeneinduced AML progression in mouse transplantation models, not only pointing to TWIST1 as an instructive signal modulating the stem cell niche, but also emphasizing the importance of the niche for AML development. 
Methods

Mice
Transplantation assays
For non-competitive BM transplantation, to create the chimeras described in Online Supplementary Figure S1A, 
Flow cytometry analysis and cell sorting
The BM cell suspensions were flushed from femora and tibiae. Spleen cells were pestled by the plug of a 10 mL syringe. The cells were then filtered through a 74 mm nylon mesh. For flow cytometric analysis of stromal cells, BM was flushed using phosphatebuffered saline with 2% bovine serum, the bones were minced with scissors, then the plugs were digested in 1 mg/mL collagenase I (OLC) or IV (MSC and EC) (Sigma-Aldrich) dissolved in Hank's balanced salt solution with 10% fetal bovine serum for 90 min (collagenase I) or 30 min (collagenase IV) at 37°C. The dissociated cells were collected and kept on ice. Cells were incubated with conjugated antibodies. Stained cells were analyzed with FACS LSR II or sorted with a FACS Aria II instrument (BD Biosciences, Franklin Lakes, NJ, USA). Data were analyzed by FlowJo software.
Statistical analysis
The significance of differences between two groups was determined using unpaired two-tailed Student t tests. Data are presented as means ± standard deviations. Overall survival curves were plotted according to the Kaplan-Meier method with the log-rank test applied for comparisons. *P<0.05, **P<0.01, ***P<0.001.
Details of other experimental procedures are given in the Online Supplementary Methods.
Results
Microenvironmental Twist1 deficiency leads to decreased numbers of mesenchymal stem cells and mature osteoblasts, an increased proportion of endothelial cells, and altered expression of cell factor genes
To explore the role of TWIST1 in the BM niche and its regulation of HSC, we generated microenvironment Twist1-deleted and control chimeric mice according to the method described by Schreck and Saez. 21, 22 In brief, 2x10 Figure S1A) . Sixteen weeks later, about 90% of the cells in the peripheral blood of recipients were donor-derived cells (Online Supplementary Figure S1B) . Tamoxifen was then injected intraperitoneally for 5 days to induce Twist1 deletion. Two weeks after the last injection, mRNA detection demonstrated that Twist1 had been knocked out in all the MSC, OLC, and EC isolated from Twist1 Δ/Δ mice with similar knockout levels (Online Supplementary Figure S1C) , while the expression of Twist2 was almost unchanged (data not shown).
To define components of the Twist1-deleted BM microenvironment that may be altered, stromal populations and extracellular factors were assessed in Twist1-deleted and control chimeric mice. We observed that conditional deletion of Twist1 led to a significant decrease in the number of MSC (CD140a 23 in the BM compared with that in control mice, as determined by flow cytometry ( Figure 1A ). The decrease in MSC number was further confirmed by a fibroblastic colony-forming unit assay (Online Supplementary Figure  S2A) . Furthermore, Twist1-deleted MSC showed a decrease in proliferative cells and an increase in apoptotic cells (Online Supplementary Figure S2B ,C), indicating the mechanism underlying the reduced number of MSC. Twist1 deficiency resulted in a marked increase in the frequency of Sca-1 -/CD166 + stromal cells ( Figure 1B ), which include immature and mature OLC. 24 Meanwhile, the expression of osteoblastic differentiation genes Runx2, Ogn and Gpnmb 14, 23 was significantly upregulated in Twist1-deleted MSC (Online Supplementary Figure S2D) . To assess the ability of MSC to differentiate into the osteoblastic lineage, we induced osteoblast differentiation in MSC and found that Twist1 deletion clearly increased alkaline phosphatase activity and matrix mineralization (Online Supplementary Figure S2E) . These results establish that Twist1 deficiency enhanced MSC commitment toward osteoblasts. However, expression of the mature osteoblast marker, Bglap, was downregulated (Online Supplementary Figure S2F ). In addition, micro-computed tomography analysis also revealed a significant decrease in mature osteoblasts in Twist1-deleted mice, which was reflected by a reduction of trabecular volume ( Figure 1C ). Collectively, Twist1 deletion promotes MSC to differentiate toward the osteoblast lineage with a block of mature osteoblast differentiation.
Emerging data demonstrate the role of vascular EC in HSC maintenance, and arterioles and sinusoids exhibit different properties in relation to HSC distribution and quiescence. 4 
Sca1
-populations enriched for total EC, arteriolar EC and sinusoidal EC, 28 respectively ( Figure 1D ). The increase of arteriolar and sinusoidal EC was further confirmed by the observation that arteries (Sca-1-staining) and sinusoids (Endoglin-staining) were both significantly increased in Twist1-deleted mice compared with control mice by immunofluorescence of femoral sections ( Figure 1E ). The increase of EC may be the result of cell proliferation as determined by increased bromodeoxyuridine incorporation into CD45 Ter119   -CD31 + stromal cells in Twist1-deleted mice ( Figure 1F ). We next performed a tube formation assay to determine the effect of TWIST1 on new blood vessel development. Consistent with increased microvessels in knockout mice in vivo, capillary tube formation of Twist1-deleted EC was also increased on matrigel ( Figure 1G ,H), indicating that Twist1 deletion promotes angiogenesis.
To further evaluate the impact of Twist1 deficiency on cell factors, we performed quantitative real-time polymerase chain reaction to analyze the expression of key niche factors. The results showed significant decreases in the expression of Cxcl12, Vcam1, Angiopoietin-1 (Angpt1) and Scf, particularly the membrane-bound isoform Scf (m220 Scf), which was found to be extremely important for HSC maintenance, in MSC (5×10 4 cells) from Twist1-deleted mice as compared to control mice ( Figure 2A ). The expression of Opn, which negatively regulates the HSC pool, was obviously increased in both MSC and OLC ( Figure 2B ). Enzyme-linked immunoassay demonstrated the reduced protein levels of CXCL12, VCAM1, SCF and elevated level of osteopontin ( Figure 2C ) in BM supernatants of Twist1-deleted mice as compared to those in control mice.
Collectively, Twist1 deletion leads to significant alterations in various key niche components, demonstrating its functional importance in the BM microenvironment, and implying its potential regulatory role in HSC maintenance.
Microenvironmental Twist1 deficiency impairs the homing and retention of hematopoietic stem cells but promotes their mobilization
Most HSC are retained in the BM niche in a quiescent, nonmotile mode by adhesion to stromal cells, which are essential for normal hematopoiesis and for protection from myelotoxic injury. Twist1 deletion resulted in decreased expression of BM CXCL12 and VCAM1, which are critical for HSC retention, homing and mobilization, 29, 30 implying that TWIST1 may have a functional impact on the migration of HSC. We first evaluated homing of normal HSC to the BM of Twist1-deleted mice. Freshly isolated c-Kit + cells from B6.SJL (CD45.1) mice were injected into lethally irradiated Twist1-deleted or control mice. Sixteen hours after transplantation, the absolute number of CD45.1 + and CD45.1 + LSK (Lin -Sca-1 + c-Kit + ) cells was significantly decreased in Twist1-deleted mice compared to the number in controls ( Figure 3A ), indicating that Twist1 deficiency impairs homing of hematopoietic stem/progenitor cells (HSPC) to the BM microenvironment.
We next determined the contribution of TWIST1 to HSC retention and mobilization by assessing total cells and HSPC in the BM, spleen and peripheral blood of haematologica | 2018; 103(12) Granulocyte colony-stimulating factor (G-CSF) is a hematopoietic cytokine known as the prototypic mobilizing agent. 31 To determine whether Twist1 deletion promot- Figure S3A,B) . We next assessed HSPC mobilization after infusion of exogenous G-CSF and found that Twist1 deletion significantly increased exogenous G-CSF-induced mobilization of total cells and colony-forming cells to the blood and spleen, and SLAM LSK to the spleen (Online Supplementary Figure S3C-H) . Taken together, these results demonstrate a functional role of TWIST1 in HSC homing, retention, baseline mobilization and stress mobilization in response to G-CSF.
Twist1 deficiency impairs hematopoietic stem cell quiescence and self-renewal, and induces enhanced early myeloid lineage differentiation Quiescence, self-renewal and committed differentiation are important properties of HSC, which could be controlled by stromal cells, extracellular matrix, cytokines and chemokines. 32, 33 Our study revealed that Twist1 deletion altered multiple stromal cells and the level of expression of HSC supportive factors, so we next investigated whether these HSC features were consequently changed. Immunophenotypic analysis demonstrated that Twist1 deletion resulted in a significant decrease in the number of long-term HSC (CD34 -Flt3 -LSK) in the BM (Online Supplementary Figure S4A) . Ki67 staining revealed a significant decrease in the percentage of HSC (CD34 -LSK) in G 0 phase in Twist1-deleted mice, together with an increase in G 1 phase ( Figure 4A ). Bromodeoxyuridine labeling further identified a higher frequency of proliferating cells in CD34 -LSK cells from Twist1-deleted mice compared to control mice ( Figure 4B ). These data suggest that TWIST1 in the microenvironment plays an important role in maintaining HSC quiescence, and loss of Twist1 drives aberrant proliferation of HSC.
To clarify the role of TWIST1 in HSC self-renewal, we conducted serial transplantation assays ( Figure 4C) Figure  4G,H) . These results suggest that Twist1 deletion in niche cells promotes HSC differentiation into the myeloid lineage. We observed that apart from the increase of HSPC in the spleen of Twist1-deleted mice, the numbers of mature myeloid cells and erythrocytes were also increased, while the number of lymphoid cells remained unchanged (Online Supplementary Figure S4B-D) , indicating the occurrence of extramedullary hematopoiesis in the spleen of Twist1-deleted mice.
Taken together, these data suggest that TWIST1 in the BM microenvironment plays a critical role in HSC maintenance, and Twist1 deletion impairs all the fundamental features of HSC.
Twist1 deficiency promotes progression of MLL-AF9-induced acute myeloid leukemia
It has been reported that the MLL-AF9 AML model exhibited multiple alterations in the niche compartments, including decreased frequencies of MSC and osteoblasts, an increased number of vascular EC, and downregulated expression of Vcam1, Cxcl12, Angpt1, and Scf, together with upregulation of Opn. 34 Intriguingly, these phenotypes are quite similar to the niche alterations in our Twist1-deleted mice. Considering the emerging importance of the BM niche for leukemia maintenance and progression, we were tempted to speculate that the altered niche in Twist1-deleted mice may play a role in the development of MLL-AF9 AML. To validate this hypothesis, we transduced WT BM c-Kit + cells with retrovirus expressing MLL-AF9, and injected these cells into lethally irradiated WT recipient mice, in which the disease was rapidly induced with massive BM and spleen infiltration of GFP + leukemic cells. We next injected 5×10 5 GFP + spleen cells from these mice into Twist1-deleted and control chimeric recipient mice ( Figure 5A) . Notably, the overall survival of Twist1-deleted recipients was significantly shorter than that of control recipients ( Figure 5B ), and Twist1-deleted recipient mice exhibited a greater infiltration of total cells and leukemic cells in the BM, peripheral blood and spleen than that of control mice (Online Supplementary Figure S5A- 36 We found that the infiltration of leukemic GMP cells was significantly increased in the BM and periphery of Twist1-deleted recipient mice compared to control mice ( Figure 5C,D) , and so was that of GFP ) in the G 0 phase was decreased and that in the G 1 or S/G 2 /M phases was increased in both BM and spleen from Twist1-deleted mice, but rates of LSC apoptosis in BM and spleen did not differ between Twist1-deleted and control mice (Online Supplementary Figure S6D-G) . We then performed secondary transplants using LSC ( Figure 5A ), injecting 5000 GFP + c-Kit + Gr-1 -cells isolated from Twist1-deleted and control mice into WT recipient mice. We found that the survival of the secondary recipients of LSC grafts from leukemic Twist1-deleted donors was significantly reduced compared to that of recipients of control LSC grafts ( Figure 5E ).
Taken together, these results demonstrate that the altered niche in Twist1-deleted mice accelerates the pro-gression of MLL-AF9-induced AML by increasing the expansion and leukemogenic capacity of LSC.
Microenvironmental Twist1 deletion promotes acute myeloid leukemia development partially through the Notch signaling pathway
To understand the mechanism underlying TWIST1 function in the development of AML, we performed RNAsequencing analysis on BM stromal cells isolated from Twist1-deleted or control chimeric mice. There were 6948 differentially expressed genes (4764 downregulated and 2184 upregulated; fold change of >2 and P value <0.05). Analysis of leukemia-related signaling revealed a marked increase of Jagged-2 expression in stromal cells from Twist1-deleted mice ( Figure 6A ). Previous studies have demonstrated that TWIST1 regulates the Notch pathway in TWIST1 regulates normal hematopoiesis and leukemia haematologica | 2018; 103 (12) 1975 37, 38 Moreover, aberrant Notch signaling is a common mechanism in niche-induced AML and pre-leukemic conditions. [39] [40] [41] [42] To investigate whether Twist1 deficiency promotes the development of MLL-AF9 AML through Notch signaling, we determined the expression of all Notch ligands (Dll1, Dll3, Dll4, Jagged-1, Jagged-2) in MSC, OLC and EC of Twist1-deleted mice. The results revealed that Jagged-2 was significantly upregulated in all these cells (Figure 6B-D) . Additionally, the levels of expression of all four Notch receptors (Notch1-4), cleaved Notch1 and the Notch targets Dtx, Hes1, Hes5, Hey1, and Hey2 were significantly upregulated in LSC from Twist1-deleted mice compared to those of controls ( Figure 6E-G) , indicating increased Notch signaling in this population. Furthermore, pharmacological inhibition of Notch signaling with a g-secretase inhibitor (DBZ) (Figure 6H-K) or blockade of Notch with dominantnegative MAML1 (DNMAML1) (Online Supplementary Figure S7 ) partially rescued leukemic cell infiltration and LSC engraftment, and prolonged the overall survival of Twist1-deleted recipients. These data suggest that a Twist1-deleted microenvironment contributes to MLL-AF9 AML development at least in part via Notch signaling.
Discussion
In the current study, we demonstrated that excision of the Twist1 gene from the BM microenvironment resulted in a significant decrease in the numbers of MSC and mature osteoblasts, and an increase in the number of EC. The expression of CXCL12, VCAM1 and SCF was reduced, while that of osteopontin was increased. These changes led to a marked impairment of HSC localization, selfrenewal, quiescence and differentiation. By transplanting MLL-AF9 cells into the Twist1-deleted and control chimeric mice, we verified that Twist1 deletion resulted in accelerated development of leukemia, at least partially through Notch signaling (Figure 7) . These results reveal the essential role of TWIST1 in supporting normal hematopoiesis and perturbing AML development.
In our model, Twist1 deletion in the BM microenvironment leads to an increased number of EC and microvessel density, suggesting the existence of an indirect and powerful mechanism for promoting angiogenesis in vivo. Ohki et al. reported that G-CSF can markedly increase vascular endothelial growth factor (VEGF) release from G-CSFresponsive myelomonocytic cells, which promote the corecruitment of VEGFR1 + (VEGF receptor 1) cells contributing to neo-angiogenesis. 43 Since we have found elevated G-haematologica | 2018; 103(12) Figure S8A,B) . These observations provide a possible explanation for the EC alterations, i.e., Twist1 deficiency in the BM microenvironment leads to increased production of G-CSF, which in turn induces the secretion of VEGF, exerting a promotive effect on the proliferation of EC. This effect overrides the direct inhibitory role of Twist1 deletion on EC, and results in increased numbers of EC. As VEGF can be produced by various cell types, the specific mechanism needs further investigation.
Our understanding of niche contributions to AML has increased tremendously over the past decade. However, most studies have focused on how the leukemic cells actively shape their microenvironment to reinforce disease progression. There are a limited number of reports showing that certain niche alterations can act as a driver of AML initiation or progression, without having been educated by leukemic cells. 40, 44, 45 Our present study demonstrates that environmental deletion of Twist1, a conserved transcriptional factor gene, results in diverse cellular and factor alterations common to the microenvironmental dysregulation exhibited by AML. These alterations appear to be predis-TWIST1 regulates normal hematopoiesis and leukemia haematologica | 2018; 103 (12) 1977 The opposing effects of TWIST1 on normal HSC and LSC found in this study are of value. In an effort to elucidate the underlying mechanism, we performed RNAsequencing and quantitative real-time polymerase chain reaction analysis. We found that Twist1 deletion leads to increased expression of the Notch ligand Jagged-2 in all the OLC, EC and MSC. LSC from Twist1-deleted chimeric mice have robust expression of all Notch receptors and canonical downstream Notch target genes, suggesting the aberrant activation of Notch signaling. A previous report showed that Notch activation promotes expansion and self-renewal of LSC, 40 consistent with our results obtained by deletion of Twist1. We also found activation of Notch receptors and target genes in normal HSC (CD34 -LSK) after Twist1 deletion (Online Supplementary Figure S9) . In contrast to the promoting role in LSC, Notch activation in HSC has been reported to cause loss of stem cell quiescence, 46 which often correlates with impaired self-renewal capacity of HSC, in line with the observations in our mouse model. Besides the direct impact of activated Notch signaling on LSC and HSC, the augmented proliferation and infiltration of LSC compared to normal HSC could be favorable for their competition for the niche over HSC. Various studies have demonstrated that LSC could positively remodel the BM microenvironment to enhance support of LSC at the expense of HSC, 47, 48 and this remodeling may in turn further promote leukemia progression and impair normal hematopoiesis. In addition, the reduced expression of Cxcl12, Scf and Angpt1 in Twist1-deleted mice may also account for the opposing impact of Twist1 deletion on HSC and LSC, since compared with HSC, LSC are less factor-dependent. 34, 45, 49 In consideration of the important role of TWIST1 in regulating MSC, osteoblasts and EC, and to exclude the interference of hematopoietic cells, which were found to express Twist1 in our previous work, 50 we generated the chimeric mouse model, in which Twist1 was diffusely deleted in the BM microenvironment. The BM niche comprises multiple cell types, which not only closely connect but also communicate with each other via cell factors and adhesion molecules throughout the BM. Due to the complexity of the niche, an overall environmental knockout strategy will facilitate the detection of direct and indirect effects of TWIST1 on the niche components. Utilizing our model, we uncovered extensive cellular and factor alterations in the BM niche and the AML-like microenvironmental phenotype resulting from Twist1 deficiency, and demonstrated the essential role of TWIST1 in HSC maintenance and suppression of AML evolution. To refine the contribution of different cell populations, studies in which Twist1 is modified in specific stromal cell subsets are ongoing in our laboratory.
In conclusion, we used a Twist1-deficient chimera model to obtain, for the first time in vivo, direct evidence that TWIST1 in the microenvironment plays a key role in maintaining the hematopoietic phenotype and hampering leukemia progression. These findings provide new insights into the importance of the BM niche for AML development, and lay the foundation for tackling leukemia from a different angle to improve current treatments. haematologica | 2018; 103(12) 
